Kieffer Tara Lynn 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Kieffer Tara Lynn（CIK 1834835）在 1 家公司共报告 5 笔 SEC Form 4 内部人交易（最近一笔 2026-02-13）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Product Strategy Officer | 买入 | 1,575 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Product Strategy Officer | 买入 | 4,987 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Product Strategy Officer | 卖出 | 3,257 | $46,412 |
| 2025-12-05 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Product Strategy Officer | 卖出 | 2,106 | $29,968 |
| 2025-12-03 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Product Strategy Officer | 卖出 | 753 | $10,632 |
来源：SEC Form 4 申报文件 · 截至 2026-02-13